1
|
Váraljai R, Elouali S, Lueong S, Wistuba‐Hamprecht K, Seremet T, Siveke J, Becker J, Sucker A, Paschen A, Horn P, Neyns B, Weide B, Schadendorf D, Roesch A. The predictive and prognostic significance of cell‐free DNA concentration in melanoma. J Eur Acad Dermatol Venereol 2020; 35:387-395. [DOI: 10.1111/jdv.16766] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Accepted: 05/27/2020] [Indexed: 02/05/2023]
Affiliation(s)
- R. Váraljai
- Department of Dermatology University Hospital of EssenUniversity Duisburg‐Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf Essen Germany
| | - S. Elouali
- Department of Dermatology University Hospital of EssenUniversity Duisburg‐Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf Essen Germany
| | - S.S. Lueong
- Institute for Developmental Cancer Therapeutics & Division of Solid Tumor Translational Oncology (DKTK/DKFZ partner site Essen) West German Cancer Center University Hospital of Essen Essen Germany
- German Cancer Consortium and German Cancer Research Center (DKFZ) Heidelberg Germany
| | | | - T. Seremet
- Department of Medical Oncology Universitair Ziekenhuis BrusselVrije Universiteit Brussel Brussel Belgium
| | - J.T. Siveke
- Institute for Developmental Cancer Therapeutics & Division of Solid Tumor Translational Oncology (DKTK/DKFZ partner site Essen) West German Cancer Center University Hospital of Essen Essen Germany
- German Cancer Consortium and German Cancer Research Center (DKFZ) Heidelberg Germany
| | - J.C. Becker
- Department of Translational Skin Cancer Research (TSCR) University Hospital of EssenUniversity of Duisburg‐Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf Essen Germany
| | - A. Sucker
- Department of Dermatology University Hospital of EssenUniversity Duisburg‐Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf Essen Germany
| | - A. Paschen
- Department of Dermatology University Hospital of EssenUniversity Duisburg‐Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf Essen Germany
| | - P.A. Horn
- Institute for Transfusion Medicine University Hospital of Essen Essen Germany
| | - B. Neyns
- Department of Medical Oncology Universitair Ziekenhuis BrusselVrije Universiteit Brussel Brussel Belgium
| | - B. Weide
- Department of Dermatology University Medical Center Tübingen Tübingen Germany
| | - D. Schadendorf
- Department of Dermatology University Hospital of EssenUniversity Duisburg‐Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf Essen Germany
| | - A. Roesch
- Department of Dermatology University Hospital of EssenUniversity Duisburg‐Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf Essen Germany
| |
Collapse
|
2
|
Frank J, Thoms K. Reinduktion immunologischer Systemtherapien beim metastasierten Melanom – Möglichkeiten und Grenzen. J Dtsch Dermatol Ges 2020; 18:421-422. [DOI: 10.1111/ddg.14100_g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
3
|
Podlipnik S, Moreno-Ramírez D, Carrera C, Barreiro A, Manubens E, Ferrandiz-Pulido L, Sánchez M, Vidal-Sicart S, Malvehy J, Puig S. Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma. Br J Dermatol 2018; 180:1190-1197. [PMID: 29876940 DOI: 10.1111/bjd.16833] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/31/2018] [Indexed: 01/01/2023]
Abstract
BACKGROUND Many follow-up guidelines for patients with high-risk melanoma include expensive imaging studies, serum biomarkers and regular visits to the dermatologist, with little attention to cost-effectiveness. OBJECTIVES To establish the cost-effectiveness of chest-abdomen-pelvis computed tomography (CT) and brain magnetic resonance imaging (MRI) in a follow-up protocol for patients at high risk of relapse. METHODS This was a prospective single-centre cohort study of 290 patients with clinicopathological American Joint Committee on Cancer (AJCC) stage IIB, IIC and III melanoma. Patients had a body CT scan and brain MRI every 6 months and were withdrawn from the study after completing a 5-year follow-up or when metastases were detected. A cost-effectiveness analysis for each follow-up radiological procedure was performed. RESULTS Patients underwent 1805 body CT scans and 1683 brain MRIs. Seventy-six metastases (26·2%) were identified by CT or MRI. CT scan was cost-effective in the first 4 years (cost-effectiveness ratio €4710·70-€14 437·10/patient with metastasis); brain MRI was cost-effective during the first year (cost-effectiveness ratio €14 090·60/patient with metastasis). Limitations included lack of survival analysis and comparisons with willingness-to-pay thresholds. CONCLUSIONS Six-monthly CT scan of the chest, abdomen and pelvis is a cost-effective technique for the early detection of metastases in the first 4 years of follow-up in patients with AJCC stage IIC and III melanoma, and in the first 3 years in patients with AJCC stage IIB melanoma. In addition, brain MRI has been shown to be cost-effective only in the first year of follow-up in patients with AJCC stage IIC and III melanoma.
Collapse
Affiliation(s)
- S Podlipnik
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain
| | - D Moreno-Ramírez
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain
| | - C Carrera
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain.,Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.,CIBER on Rare Diseases, Instituto de Salud Carlos III, Barcelona, Spain
| | - A Barreiro
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain
| | - E Manubens
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain
| | - L Ferrandiz-Pulido
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain
| | - M Sánchez
- Department of Radiology, Hospital Clinic of Barcelona, University of Barcelona, Spain
| | - S Vidal-Sicart
- Department of Nuclear Medicine, Hospital Clinic of Barcelona, University of Barcelona, Spain
| | - J Malvehy
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain.,Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.,CIBER on Rare Diseases, Instituto de Salud Carlos III, Barcelona, Spain
| | - S Puig
- Department of Dermatology , Hospital Clinic of Barcelona, University of Barcelona, Spain.,Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.,CIBER on Rare Diseases, Instituto de Salud Carlos III, Barcelona, Spain
| |
Collapse
|
4
|
Steinbach J, Vordermark D, Gutzmer R. [CNS metastases--an interdisciplinary challenge]. ONKOLOGIE 2013; 36 Suppl 4:2-6. [PMID: 23797363 DOI: 10.1159/000350920] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Joachim Steinbach
- Dr. Senckenbergisches Institut für Neuroonkologie, Zentrum der Neurologie und Neurochirurgie, Frankfurt/Main, Germany
| | | | | |
Collapse
|